Brief: Ossdsign Announces Strategic Shift To Become A Pure Play Orthobiologics Company
26/09/2023 16:34
Sept 26 (Reuters) - OssDsign AB OSSD.ST :
* OSSDSIGN ANNOUNCES STRATEGIC SHIFT TO BECOME A PURE PLAY
ORTHOBIOLOGICS COMPANY
* TARGET IS TO REACH SALES OF SEK 150-200 MILLION IN
MEDIUM-TERM,
AT WHICH POINT COMPANY ALSO EXPECTS TO BECOME CASH FLOW POSITIVE
* OSSDSIGN- ALL ACTIVITIES PERTAINING TO CO'S
PATIENT-SPECIFIC
CRANIAL IMPLANT BUSINESS WILL BE DISCONTINUED IN A RESPONSIBLE
MANNER BY END OF DEC 2023
* AS A RESULT OF SHIFT FUTURE CAPITAL REQUIREMENT AHEAD OF
BECOMING CASH FLOW POSITIVE WILL BE SIGNIFICANTLY DECREASED
Source text for Eikon: ID:nWkr84BS6R
Further company coverage: OSSD.ST
((Reuters.Briefs@thomsonreuters.com;))